Incretin-based therapies for the treatment of type 2 diabetes: Evaluation of the risks and benefits

Daniel J. Drucker, Steven I. Sherman, Fred S. Gorelick, Richard M. Bergenstal, Robert S. Sherwin, John B. Buse

Research output: Contribution to journalReview articlepeer-review

268 Scopus citations

Fingerprint

Dive into the research topics of 'Incretin-based therapies for the treatment of type 2 diabetes: Evaluation of the risks and benefits'. Together they form a unique fingerprint.

Medicine & Life Sciences